drugset / Trial / NCT01919697
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a multi-center, open-label, 52-week safety and tolerability study of plecanatide in patients with Chronic Idiopathic Constipation (CIC).
Timeline
- Start
- 2013-08
- Primary completion
- 2016-01
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Plecanatide | Peptide | 3 mg | Oral |
| Subject | Plecanatide | Peptide | 6 mg | Oral |